Institutional investors increase stakes in Zimmer Biomet and Vertex Pharmaceuticals

Recent SEC filings reveal significant institutional investment activity in healthcare companies Zimmer Biomet Holdings, Inc. and Vertex Pharmaceuticals Incorporated during the second quarter.

Regarding Zimmer Biomet, First National Bank of Omaha acquired 140,635 shares valued at approximately $12.55 million. DCF Advisers LLC also established a new position with 30,500 shares worth roughly $2.63 million. Other investors, including United Bank and Cerity Partners LLC, have also modified or increased their holdings in the medical equipment provider.

In the pharmaceutical sector, Vertex Pharmaceuticals saw substantial interest from several firms. E Fund Management Co. Ltd. acquired 11,455 shares valued at approximately $5.69 million, while DCF Advisers LLC purchased 11,500 shares worth about $5.71 million. Other institutional investors, such as Knuff & Co LLC and NewEdge Wealth LLC, also established new positions in the company.